1.Indian Pharmacopoeia Commission Mandate (Drug Standards)

What & Where
Indian Pharmacopoeia Commission (IPC) = autonomous body issuing Indian Pharmacopoeia, legal drug-quality standard for India.
Core processes: monograph revision, pharmacovigilance, reference-substance certification, National Formulary publication.
Geography: HQ Ghaziabad (Uttar Pradesh); administratively under Ministry of Health & Family Welfare.
Quick Facts for MCQs
Legal & Policy
- Autonomy granted yet administratively controlled by MoHFW ensuring swift revision without bureaucratic delay.
- Alignment with Drugs & Cosmetics Act provides statutory enforceability of published standards.
- Full GoI funding safeguards impartiality from industry influence.
Key Functions
- Publication: revises ~every 4-5 years covering APIs, excipients, devices, herbals.
- Surveillance: PvPI collects, analyses adverse-drug-reaction data nationwide.
- Standards: certifies reference substances enabling lab validation across India.
International Angle
- Recognition by 19 countries elevates Indian formulations’ export acceptability.
- Harmonisation with six leading pharmacopoeias reduces duplicate testing for global supply chains.
- Supports pharma diplomacy, positioning India as pharmacy-of-the-world.
Economic Impact
- Robust domestic standards strengthen generics credibility, aiding $25 bn pharmaceutical export market.
- Training & self-reliance cut dependence on costly overseas reference standards.
Key Data Points
| Feature | Data-Point |
|---|---|
| Operational since | 1 Jan 2009 |
| Legal mandate | Drugs & Cosmetics Act 1940 |
| Institutional type | Autonomous, fully GoI-funded |
| Parent ministry | MoHFW |
| Headquarters | Ghaziabad, Uttar Pradesh |
| Upcoming edition | 10th IP 2026, to launch Jan 2026 |
| Current flagship book | Indian Pharmacopoeia (drug standards) |
| Companion booklet | National Formulary of India |
| Pharmacovigilance role | National Coordination Centre, PvPI |
| Reference materials | Issues IP Reference Substances |
| Global ties | Harmonises with USP, BP, Ph.Eur., JP, ChP, WHO-IP |
| International recognition | IP accepted in 19 countries |
| Public-health aim | Ensure identity, purity, strength, safety of medicines |
| National missions served | Atmanirbhar Bharat, Viksit Bharat |
| Capacity building | Runs training & research on regulatory science |
Related UPSC Prelims PYQs
Which organization developed the Online National Drugs Licensing System (ONDLS) portal?








